ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 3.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $542,000 | -0.4% | 164,200 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $544,000 | -1.8% | 164,200 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $554,000 | -8.3% | 164,200 | +4.2% | 0.00% | -50.0% |
| Q1 2020 | $604,000 | -77.7% | 157,600 | -64.8% | 0.01% | -71.4% |
| Q4 2019 | $2,704,000 | -20.1% | 447,600 | 0.0% | 0.03% | -22.2% |
| Q3 2019 | $3,384,000 | -30.4% | 447,600 | +24.7% | 0.04% | +200.0% |
| Q2 2019 | $4,860,000 | +400.0% | 358,800 | +100.0% | 0.01% | +100.0% |
| Q1 2019 | $972,000 | +265.4% | 179,400 | +450.3% | 0.01% | +200.0% |
| Q3 2018 | $266,000 | -16.4% | 32,600 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $318,000 | -3.0% | 32,600 | -13.5% | 0.00% | 0.0% |
| Q1 2018 | $328,000 | +1.9% | 37,700 | -1.8% | 0.00% | 0.0% |
| Q3 2017 | $322,000 | -16.6% | 38,400 | +100.0% | 0.00% | 0.0% |
| Q1 2017 | $386,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ETF MANAGERS GROUP, LLC | 2,679,457 | $20,257,000 | 0.73% |
| Portolan Capital Management | 777,293 | $5,876,000 | 0.66% |
| CAMPBELL CAPITAL MANAGEMENT INC | 110,451 | $835,000 | 0.62% |
| ZEKE CAPITAL ADVISORS, LLC | 402,212 | $3,041,000 | 0.27% |
| Leap Investments LP | 46,084 | $348,000 | 0.17% |
| Bernardo Wealth Planning LLC | 26,419 | $199,000 | 0.14% |
| Claraphi Advisory Network, LLC | 14,744 | $111,000 | 0.07% |
| Sterling Investment Advisors, Ltd. | 11,000 | $83,000 | 0.04% |
| A.R.T. Advisors, LLC | 81,372 | $615,000 | 0.03% |
| Mirae Asset Global Investments Co., Ltd. | 544,408 | $4,116,000 | 0.03% |